These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4796885)

  • 1. Interactions of several cannabinoids with the hepatic drug metabolizing system.
    Fernandes M; Warning N; Christ W; Hill R
    Biochem Pharmacol; 1973 Dec; 22(23):2981-7. PubMed ID: 4796885
    [No Abstract]   [Full Text] [Related]  

  • 2. Product inhibition during the hepatic microsomal N-demethylation of aminopyrine in the rat.
    Bast A; Noordhoek J
    Biochem Pharmacol; 1981 Jan; 30(1):19-24. PubMed ID: 7213410
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the effects of 1 -tetrahydrocannabinol ( 1 -THC) and DDT on the hepatic microsomal metabolism of 1 -THC and other compounds in the rat.
    Kupfer D; Levin E; Burstein SH
    Chem Biol Interact; 1973 Jan; 6(1):59-66. PubMed ID: 4689910
    [No Abstract]   [Full Text] [Related]  

  • 4. Difference spectra of rat hepatic microsomes induced by cannabinoids and related compounds.
    Bailey K; Toft P
    Biochem Pharmacol; 1973 Nov; 22(21):2780-3. PubMed ID: 4763612
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo and in vitro effects of delta9-tetrahydrocannabinol on rats liver microsomal drug-metabolizing enzymes.
    Mitra G; Poddar MK; Ghosh JJ
    Toxicol Appl Pharmacol; 1976 Mar; 35(3):523-30. PubMed ID: 1265765
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-competitive and competitive inhibition of mixed function oxidase in rat liver microsomes by metyrapone.
    Roots I; Hildebrandt AG
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 277(1):27-38. PubMed ID: 4350469
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of pyridine and some pyridine derivatives on spectral properties of reduced microsomes and on microsomal drug metabolizing activity.
    Jonen HG; Hüthwohl B; Kahl R; Kahl GF
    Biochem Pharmacol; 1974 Apr; 23(8):1319-29. PubMed ID: 4824776
    [No Abstract]   [Full Text] [Related]  

  • 8. The intracellular localization of 9 -tetrahydrocannabinol in liver and its effects on drug metabolism in vitro.
    Dingell JV; Miller KW; Heath EC; Klausner HA
    Biochem Pharmacol; 1973 Apr; 22(8):949-58. PubMed ID: 4693827
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of 1-alkylimidazoles on hepatic drug-metabolizing enzyme activity.
    Palmer ED; Cawthorne MA
    Xenobiotica; 1974 Apr; 4(4):209-17. PubMed ID: 4847029
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction between ethanol metabolism and mixed-function oxidation in alcohol dehydrogenase positive and negative deermice.
    Gellert J; Alderman J; Lieber CS
    Biochem Pharmacol; 1986 Mar; 35(6):1037-41. PubMed ID: 2937407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of oxine-5-sulphonic acid on the hepatic drug metabolism in the rat.
    Manzo L; Passoni R; Segre AD; Berte F; Crema A
    Experientia; 1976 Oct; 32(10):1318-20. PubMed ID: 824156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of hepatic drug-metabolizing enzymes by pyridoxine-5-disulfide 2HCl-2H 2 O(pyrithioxine).
    Endo Y; Uchiyama M
    Biochem Pharmacol; 1970 Nov; 19(11):2839-51. PubMed ID: 4997719
    [No Abstract]   [Full Text] [Related]  

  • 13. 25-Hydroxycholecalciferol: high affinity substrate for hepatic cytochrome P-450.
    Cinti DL; Golub EE; Bronner F
    Biochem Biophys Res Commun; 1976 Sep; 72(2):546-53. PubMed ID: 985497
    [No Abstract]   [Full Text] [Related]  

  • 14. Aminopyrine demethylase--multiplicity shown by dieldrin and DDT inhibition.
    Aust SD; Stevens JB
    Biochem Pharmacol; 1971 Jun; 20(6):1061-9. PubMed ID: 5118109
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of hepatic mixed function oxidase activity by propyl gallate.
    Yang CS; Strickhart FS
    Biochem Pharmacol; 1974 Nov; 23(22):3129-38. PubMed ID: 4155301
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of nicotinamide on microsomal drug-metabolizing activity in vitro.
    Müller D; Klinger W
    Exp Pathol (Jena); 1979; 17(7-8):474-8. PubMed ID: 159831
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of microsomal drug-metabolizing enzymes from rat liver by various 4-hydroxycoumarin derivatives.
    Christensen F; Wissing F
    Biochem Pharmacol; 1972 Apr; 21(7):975-84. PubMed ID: 4114280
    [No Abstract]   [Full Text] [Related]  

  • 18. [Demethylation of aminophenazone and codeine in human liver. An investigation of microsomal electron transport].
    Ackermann E
    Biochem Pharmacol; 1970 Jun; 19(6):1955-73. PubMed ID: 4398024
    [No Abstract]   [Full Text] [Related]  

  • 19. The occurrence of an inhibitor of lipid peroxidation in rat liver soluble fraction and its effect on microsomal drug oxidations.
    Kamataki T; Ozawa N; Kitada M; Kitagawa H; Sato R
    Biochem Pharmacol; 1974 Sep; 23(17):2485-90. PubMed ID: 4373005
    [No Abstract]   [Full Text] [Related]  

  • 20. Partial inhibition of hepatic microsomal aminopyrine N-demethylase by caffeine in partially purified cytochrome P450.
    Govindwar SP; Kachole MS; Pawar SS
    Biochim Biophys Acta; 1983 Mar; 756(2):191-5. PubMed ID: 6830852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.